Authors



Daniel Breeman

Latest:

What the crystal ball holds: Experts give their take

Q Will there be a pharmacy shortage 25 years from now? How will the role of the pharmacist change?


Howard Mirsky, PharmB

Latest:

FDA's standstill on N-9 endangering women's lives

This hasn't been a banner year for the Food & Drug Administration as guardian of our health and safety, for a storm of controversy has been following the agency like the black cloud that hovered over the head of cartoon character Mr. Mxyzptlk.



Fred Gebhart

Latest:

How to Manage Medication Risks

Managing the overall risk of medication therapy is more effective than simply managing drug-drug interactions.


Christine Blank

Latest:

Antibiotics Linked to Higher IBD Risk in Older Adults

Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.


James Rawlings, RPh

Latest:

C’mon, folks, give them the chair!

Popular contributor "Goose" Rawlings offers a simple solution to a universal problem.


Julia Talsma, Content Channel Director

Latest:

ASHP offers quality improvement strategies in new resource center

The American Society of Health-System Pharmacists (ASHP) is providing quality improvement strategies for pharmacy practice settings across the continuum of care.


Julianne Stein, Content Channel Manager

Latest:

Milenkovich joins Roetzel & Andress

Drug Topics’ legal compliance columnist named partner in Roetzel's Chicago office and head of the firm’s Drug and Pharmacy practice.


Miranda Hester

Latest:

Looking to the Future of Independent Pharmacy

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.


Mark Lowery, Editor

Latest:

Sandoz to offer generic Solaraze

Sandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.


Kevin W. Chamberlin, PharmD

Latest:

FDA Approves Voquezna for Helicobacter pylori Infection in Adults

This new treatment option copackages 3 drugs for optimal treatment.


Donna Marbury

Latest:

Six Healthcare Technologies Coming in the Next Five Years

Healthcare execs need to lay the cultural foundation today for upcoming technology changes


Kathryn Wheeler, PharmD, BCPS

Latest:

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.


Tracey Walker, Contributing Editor

Latest:

FDA lifts some restrictions on diabetes drug Avandia

Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.


Larry LaBenne, PharmD, CDE

Latest:

Teachable moments: Take your best shot

When it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.



Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP

Latest:

The hydrocodone question

Asking whether hydrocodone should be rescheduled is only the beginning.


Joseph Friedman, RPh, MBA

Latest:

Should you establish a medical marijuana dispensary?

If your inner entrepreneur is hollering to get out, maybe you should go for it.



Peter A. Kreckel, RPh

Latest:

Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder

Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs.


Perry Cohen, PharmD, FAMCP

Latest:

It's Time for Pharmacists to Carve Out a New Role

Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.


Susan Egbert

Latest:

Patients and Herbal Supplements

Your patients are using herbal products, but do you know enough about them?


David Stanley, RPh

Latest:

Hold the phone

How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.


John Schieszer, MA

Latest:

Barriers Coming Down for Complex Generic Drug Products

This year may mark a dramatic difference in the development and approval of complex generic drug products.


Jeff Cineas, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Stephanie Trexler, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Dustyn Williams, MD

Latest:

Diabetes Management and the Promise of Telemedicine

Could telemedicine be the answer to diabetes management problems?


Zoe Barry

Latest:

Fixing a Broken System with Technology

Technology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.


Paul Armentano

Latest:

Making the Case for Regulated Marijuana

Pharmacists urged to support controls to the marijuana market but oppose criminalization.

© 2025 MJH Life Sciences

All rights reserved.